Previsioni del mercato europeo delle particelle virus-simili fino al 2028: impatto del COVID-19 e analisi regionale per tipo di prodotto (epatite, cancro/HPV e malattia di Gaucher), fonte (lievito, cellule di insetti, piante e altri) e applicazione (vaccini e vaccini). terapeutica)

Introduzione al mercato

L\'Europa comprende cinque paesi importanti, vale a dire Germania, Francia, Regno Unito, Italia e Spagna. Il mercato comprende anche il resto dei paesi europei. Il mercato europeo delle particelle virus-simili sta registrando una crescita più forte grazie alle approvazioni di nuovi prodotti da parte degli organismi autorizzati. Ad esempio, il primo vaccino autorizzato contro la malaria basato su VLP, ovvero \"Mosquirix\", è stato approvato dalle autorità di regolamentazione europee. Inoltre, paesi come Regno Unito, Germania, Francia, Italia e Spagna sono i principali paesi che contribuiscono a stimolare la domanda di prodotti contenenti particelle simili a virus in Europa.

Secondo il Secondo il rapporto dell’Organizzazione Mondiale della Sanità (OMS), attualmente ogni singolo paese in Europa si trova ad affrontare una reale minaccia di COVID-19. Il ritmo della trasmissione del virus nei 53 paesi della regione europea dell’OMS è motivo di preoccupazione. Per controllare la trasmissione, i paesi europei stanno effettuando la vaccinazione in varie fasi. In Europa, vari vaccini contro il COVID-19 sono attualmente in fase di sviluppo e sono in fase di sperimentazione clinica, in paesi come Regno Unito, Germania e Russia. Tra questi, ci sono tre vaccini nel Regno Unito, tre vaccini in Germania e due in Russia. Tra questi vaccini c\'è un vaccino inattivato, due subunità proteiche, tre vaccini con vettori virali e due vaccini con acidi nucleici. Per combattere il coronavirus nella regione europea, l’Europa nel suo insieme ha compiuto sforzi costanti per promuovere lo sviluppo di vaccini. Il rapporto Bruegel afferma che, prima della pandemia di COVID-19, l’UE aveva annunciato un finanziamento di quasi 500 milioni di dollari per la ricerca sui vaccini e sulle vaccinazioni attraverso il programma di ricerca Orizzonte 2020 nel periodo 2014-2020. Inoltre, per combattere il COVID-19, l’UE ha offerto fondi di emergenza per sostenere la ricerca e lo sviluppo di strumenti diagnostici, terapeutici e vaccini. Inizialmente, 10 milioni di dollari sono successivamente aumentati a 47,5 milioni di dollari e sono stati assegnati a progetti di ricerca per rispondere alla pandemia di COVID-19. Inoltre, l\'Istituto europeo di tecnologia sanitaria, inaugurato nell\'aprile 2020, è stato un invito ai partner dell\'EIT a inviare proposte per progetti COVID-19 con una solida attuazione e il finanziamento di ciascun progetto.

< strong>Panoramica e dinamiche del mercato

Si prevede che il mercato delle particelle virus-simili in Europa crescerà da 1.302,03 milioni di dollari nel 2021 a 2.203,61 milioni di dollari entro il 2028; si stima che crescerà a un CAGR del 7,8% dal 2021 al 2028. I vaccini costituiscono uno dei segmenti significativi dell\'industria farmaceutica. Hanno una vasta applicazione nell\'immunizzazione degli esseri umani e degli animali contro le infezioni comuni. Le aziende che operano nei mercati farmaceutico e biofarmaceutico si concentrano continuamente sulle innovazioni e sugli sviluppi dei prodotti per sostenere la concorrenza sul mercato. Ad esempio, gli operatori del mercato hanno investito in modo significativo nello sviluppo di vaccini contro il COVID-19 e in studi relativi alla VLP. Gli sviluppi attivi da parte delle aziende del settore delle scienze della vita, insieme al sostegno del governo per le stesse, stanno contribuendo alla crescita del mercato VLP.

Segmenti chiave del mercato

In termini di tipologia di prodotto, il segmento dell\'epatite ha rappresentato la quota maggiore del mercato europeo delle particelle virus-simili nel 2021. In termini di fonte, il Il segmento del lievito ha rappresentato la quota maggiore del mercato europeo delle particelle simili a virus nel 2021. In termini di applicazione, il segmento dei vaccini ha detenuto una quota di mercato maggiore del mercato delle particelle simili a virus nel 2021.

Principali fonti e aziende elencate

Alcune delle principali fonti primarie e secondarie citate per la preparazione del presente rapporto Sul mercato delle particelle virus-simili in Europa si trovano, tra gli altri, siti web aziendali, relazioni annuali, relazioni finanziarie, documenti governativi nazionali e database statistici. Le principali società elencate nel rapporto sono Merck & Co., Inc.; GlaxoSmithKline plc.; Pfizer Inc.; Sanofi; Istituto del siero dell\'India Pvt. Ltd.; BIOTECNOLOGIA BHARAT; LG Chem; e Dynavax Technologies tra gli altri.

Motivi per acquistare il rapporto

Comprendere il panorama del mercato europeo delle particelle simili a virus e identificare i segmenti di mercato che hanno maggiori probabilità di garantire un forte rendimento
Stai al passo con la corsa comprendendo il panorama competitivo in continua evoluzione per il mercato europeo delle particelle simili ai virus
Pianifica in modo efficiente M& ;A e accordi di partnership nel mercato europeo delle particelle simili a virus identificando i segmenti di mercato con le vendite probabili più promettenti
Aiuta a prendere decisioni aziendali consapevoli grazie a un\'analisi perspicace e completa delle prestazioni del mercato di vari segmenti del mercato europeo delle particelle simili a virus
Ottieni previsioni sulle entrate del mercato per vari segmenti dal 2021 al 2028 nella regione europea.

Segmentazione del mercato europeo delle particelle virus-simili

Mercato europeo delle particelle virali - per tipo di prodotto

Epatite
Cancro/HPV
Malattia di Gaucher

Mercato europeo delle particelle simili a virus - per fonte

Lievito
Cellula di insetto
Pianta
Altri

Mercato europeo delle particelle simili a virus - Di Applicazione

Vaccini
Terapeutici

Mercato europeo delle particelle simili a virus - Per Paese

Mercato europeo delle particelle simili a virus - Aziende citate

Merck & Co., Inc. ; \' bsp ;
GlaxoSmithKline plc.
Pfizer Inc. ; \' bsp ; \' bsp ;
Sanofi ; \' bsp ; \' bsp ; \'
Serum Institute of India Pvt. Ltd.
BHARAT BIOTECH ; \' bsp ;
LG Chem ; ;
Dynavax Technologies

1.         Introduction
1.1         Scope of the Study
1.2         The Insight Partners Research Report Guidance
1.3         Market Segmentation
1.3.1        Europe Virus-like Particles Market – By Product Type
1.3.2        Europe Virus-like Particles Market – By Source
1.3.3        Europe Virus-like Particles Market – By Application
1.3.4        Europe Virus-like Particles Market – By Country
2.           Europe Virus-like Particles Market – Key Takeaways
3.        Research Methodology
3.1         Coverage
3.2         Secondary Research
3.3         Primary Research
4.           Europe Virus-like Particles Market Landscape
4.1         Overview
4.2         PEST Analysis
4.3         Experts Opinion
5.           Europe Virus-like Particles Market – Key Market Dynamics
5.1         Market Drivers
5.1.1        Raising Prevalence of Infectious Viral Diseases
5.1.2        The Growing Role of Virus-Like Particles in Therapeutic Developments and Studies
5.2         Market Restraints
5.2.1        Access of Alternative Technologies for Viral Vaccine Production
5.3         Market Opportunities
5.3.1        Boosting Potential Applications in Therapeutics and Diagnostics
5.4         Future Trends
5.4.1        Ongoing Demand for Innovative and Effective Products
5.5         Impact Analysis
6.           Europe Virus-like Particles Market Analysis
6.1         Europe Virus-like Particles Market Revenue Forecast and Analysis
7.           Europe Virus-like Particles Market Analysis – by Product Type
7.1         Overview
7.2         Europe Virus-like Particles Market, by Product Type, 2021 & 2028 (%)
7.3         Hepatitis
7.3.1        Overview
7.3.2        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
7.4         Cancer/ Human Papillomavirus (HPV)
7.4.1        Overview
7.4.2        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
7.5         Gaucher Disease
7.5.1        Overview
7.5.2        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.           Europe Virus-like Particles Market Analysis – By Source
8.1         Overview
8.2         Europe Virus-like Particles Market Share, by Source, 2021 & 2028 (%)
8.3         Yeast
8.3.1        Overview
8.3.2        Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.4         Plant
8.4.1        Overview
8.4.2        Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.5         Insect Cell
8.5.1        Overview
8.5.2        Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.6         Others
8.6.1        Overview
8.6.2        Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
9.           Europe Virus-like Particles Market Analysis – By Application
9.1         Overview
9.2         Europe Virus-like Particles Market Share, by Application, 2021 & 2028 (%)
9.3         Vaccines
9.3.1        Overview
9.3.2        Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
9.4         Therapeutics
9.4.1        Overview
9.4.2        Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.        Europe Virus-like Particles Market – Country Analysis
10.1      Overview
10.1.1     Europe: Virus-like Particles Market, by Country, 2021 & 2028(%)
10.1.1.1       Germany: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1       Overview
10.1.1.1.2       Germany: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3       Germany: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.4       Germany: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.5       Germany Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.2       France: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1       Overview
10.1.1.2.2       France: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3       France: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.4       France: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.5       France Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.3       UK: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1       Overview
10.1.1.3.2       UK: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3       UK: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.4       UK: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.5       UK Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.4       Italy: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1       Overview
10.1.1.4.2       Italy: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3       Italy: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.4       Italy: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.5       Italy Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.5       Spain: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1       Overview
10.1.1.5.2       Spain: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3       Spain: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.4       Spain: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.5       Spain Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.6       Rest of Europe: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1       Overview
10.1.1.6.2       Rest of Europe: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3       Rest of Europe: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.4       Rest of Europe: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.5       Rest of Europe Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
11.        Impact Of COVID-19 Pandemic on Europe Virus-like Particles Market
11.1      Impact Assessment of COVID-19 Pandemic
12.        Europe Virus-like Particles Market–Industry Landscape
12.1      Overview
12.2      Organic Developments
12.2.1     Overview
12.3      Inorganic Developments
12.3.1     Overview
13.        Company Profiles
13.1      Merck & Co., Inc.
13.1.1     Key Facts
13.1.2     Business Description
13.1.3     Products and Services
13.1.4     Financial Overview
13.1.5     SWOT Analysis
13.1.6     Key Developments
13.2      GlaxoSmithKline plc.
13.2.1     Key Facts
13.2.2     Business Description
13.2.3     Products and Services
13.2.4     Financial Overview
13.2.5     SWOT Analysis
13.2.6     Key Developments
13.3      Pfizer Inc.
13.3.1     Key Facts
13.3.2     Business Description
13.3.3     Products and Services
13.3.4     Financial Overview
13.3.5     SWOT Analysis
13.3.6     Key Developments
13.4      Dynavax Technologies
13.4.1     Key Facts
13.4.2     Business Description
13.4.3     Products and Services
13.4.4     Financial Overview
13.4.5     SWOT Analysis
13.4.6     Key Developments
13.5      Sanofi
13.5.1     Key Facts
13.5.2     Business Description
13.5.3     Products and Services
13.5.4     Financial Overview
13.5.5     SWOT Analysis
13.5.6     Key Developments
13.6      Serum Institute of India Pvt. Ltd.
13.6.1     Key Facts
13.6.2     Business Description
13.6.3     Products and Services
13.6.4     Financial Overview
13.6.5     SWOT Analysis
13.6.6     Key Developments
13.7      BHARAT BIOTECH
13.7.1     Key Facts
13.7.2     Business Description
13.7.3     Products and Services
13.7.4     Financial Overview
13.7.5     SWOT Analysis
13.7.6     Key Developments
13.8      LG Chem
13.8.1     Key Facts
13.8.2     Business Description
13.8.3     Products and Services
13.8.4     Financial Overview
13.8.5     SWOT Analysis
13.8.6     Key Developments
14.        Appendix
14.1      About The Insight Partners
14.2      Glossary of Terms

LIST OF TABLES
Table 1.             Europe Virus-like Particles Market, Revenue and Forecast to 2028 (US$ Million)
Table 2.             Germany: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 3.             Germany: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)
Table 4.             Germany Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 5.             France: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 6.             France: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)
Table 7.             France Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 8.             UK: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 9.             UK: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)
Table 10.          UK Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 11.          Italy: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 12.          Italy: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)
Table 13.          Italy Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 14.          Spain: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 15.          Spain: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)
Table 16.          Spain Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 17.          Rest of Europe: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 18.          Rest of Europe: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)
Table 19.          Rest of Europe Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 20.          Organic Developments Done by Companies
Table 21.          Inorganic Developments Done by Companies
Table 22.          Glossary of Terms: Virus-like Particles Market

LIST OF FIGURES
Figure 1.           Europe Virus-like particles Market Segmentation
Figure 2.           Europe Virus-like particles Market Segmentation, By Country
Figure 3.           Europe Virus-like Particles Market Overview
Figure 4.           Hepatitis Held the Largest Share of the Product Type Segment in Europe Virus-like particles Market
Figure 5.           The UK to Show Significant Growth during Forecast Period
Figure 6.           Europe Virus-like Particles Market, Industry Landscape
Figure 7.           Europe PEST Analysis
Figure 8.           Europe Virus-like Particles Market: Impact Analysis of Drivers and Restraints
Figure 9.           Europe Virus-like Particles Market– Revenue Forecast and Analysis to 2028
Figure 10.        Europe Virus-like Particles Market, by Product Type, 2021 & 2028 (%)
Figure 11.        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 12.        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 13.        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 14.        Europe Virus-like Particles Market Share, by Source, 2021 & 2028 (%)
Figure 15.        Yeast: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16.        Plant: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17.        Insect Cell: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18.        Others: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19.        Europe Virus-like Particles Market Share, by Application, 2021 & 2028 (%)
Figure 20.        Vaccine: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21.        Therapeutics: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22.        Europe: Virus-like Particles Market, by Key Country – Revenue (2021) (USD Million)
Figure 23.        Europe: Virus-like Particles Market, by Country, 2021 & 2028 (%)
Figure 24.        Germany: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25.        France: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26.        UK: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27.        Italy: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28.        Spain: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29.        Rest of Europe: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30.        Impact of COVID-19 Pandemic in European Country Markets

Merck & Co., Inc.
GlaxoSmithKline plc.
Pfizer Inc.
Sanofi
Serum Institute of India Pvt. Ltd.
BHARAT BIOTECH
LG Chem
Dynavax Technologies

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe virus-like particles market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe virus-like particles market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the virus-like particles market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code

Full Name

Country Name

Email Id

Phone Number

Job Title

Company

Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name Published Date

Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv.. May 2022

Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P.. May 2022

Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat.. May 2022

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount

Subscription Member Price: FREE
Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.